What is Extreme Microbial Technologies?
Extreme Microbial Technologies operates at the intersection of biotechnology and environmental engineering, specializing in advanced air and surface purification systems. By deploying sophisticated technology designed to neutralize viruses, bacteria, molds, and odors, the company addresses the critical demand for sterile indoor environments. Their solutions, which boast a 99.9% efficacy rate in pathogen reduction, serve a diverse range of sectors including healthcare, commercial real estate, and public infrastructure. As a leader in microbial control, the company is effectively bridging the gap between industrial-grade sanitation and accessible, safe indoor air quality management.
How much funding has Extreme Microbial Technologies raised?
Extreme Microbial Technologies has raised a total of $128K across 1 funding round:
Debt
$128K
Debt (2021): $128K with participation from PPP
Key Investors in Extreme Microbial Technologies
PPP
Public-Private Partnership
What's next for Extreme Microbial Technologies?
With this late-stage capital, Extreme Microbial Technologies is poised to scale its operational footprint and enhance its research and development capabilities. The strategic focus will likely shift toward expanding its distribution networks and refining its core purification technology to meet evolving global health standards. By leveraging this recent investment, the company aims to solidify its market position as a primary provider of comprehensive microbial mitigation solutions, ensuring long-term sustainability and growth in an increasingly health-conscious global economy.
See full Extreme Microbial Technologies company page
